Tatsis Ourania sold VRTX
March 10, 2025 · Form 4 insider transaction
Tatsis Ourania sold 3,242 shares of Vertex Pharmaceuticals Incorporated at $499.99 per share, a transaction worth $1.62M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,242
Price
$499.99
Total value
$1.62M
InsiderTatsis Ourania
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 10, 2025
Filing dateMarch 12, 2025
Shares owned after51,239
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 11/22/2024.